Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6072177 | Journal of the American Academy of Dermatology | 2015 | 19 Pages |
Abstract
Epstein-Barr virus (EBV) is a ubiquitous virus that has been implicated in a wide range of human diseases, many of which have mucocutaneous manifestations. As a member of the herpesviridae family, EBV causes lifelong infection by establishing latency in B lymphocytes. An intact immune response is critical in preventing progression of EBV disease, and the clinical manifestations of infection are dependent on the intricate relationship between virus and host immune system. This review provides a comprehensive overview of the epidemiology, pathophysiology, and diagnostic testing in EBV infection. In part I of this continuing medical education article, the mucocutaneous manifestations of EBV infection are reviewed with an emphasis on pathophysiology and management.
Keywords
EBNAHeterophile antibodiesHydroa vacciniformeEBERCAEBVHypersensitivity to mosquito bitesLCLPTLDVCAGCsNF-κBOHLHmbISHLMPIn situ hybridizationStat1early antigenviral capsid antigenEBVPosttransplant lymphoproliferative diseaseLatencyLangerhans cellLymphoblastoid cell lineCMVcytomegalovirusHistiocytic necrotizing lymphadenitisLymphoproliferativeOral hairy leukoplakiasignal transducer and activator of transcription 1Infectious mononucleosispolymerase chain reactionPCREpstein–Barr virusEpstein-Barr virusLatent membrane protein
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Lawrence David MD, Lindsay A. MD, Kathleen S. MD, Warren R. MD,